title: Late onset of bortezomib-associated cutaneous reaction following herpes zoster.
authors.forename: Marzia
authors.initials: M
authors.lastname: Varettoni
authors.forename: Camilla
authors.initials: C
authors.lastname: Vassallo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Borroni
authors.forename: Silvia
authors.initials: S
authors.lastname: Mangiacavalli
authors.forename: Patrizia
authors.initials: P
authors.lastname: Zappasodi
authors.forename: Renato
authors.initials: R
authors.lastname: Rosso
authors.forename: Mario
authors.initials: M
authors.lastname: Lazzarino
authors.forename: Alessandro
authors.initials: A
authors.lastname: Corso
mesh_terms: D000212:Acyclovir / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001897:Boronic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D000069286:Bortezomib; D003907:Dexamethasone / Q000627:therapeutic use; D005076:Exanthema / Q000139:chemically induced* / Q000188:drug therapy; D006562:Herpes Zoster / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000473:pathology / Q000821:virology; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone; D000212:Acyclovir